» Articles » PMID: 9893347

Vascular Endothelial Growth Factor Receptor-3

Overview
Date 1999 Jan 20
PMID 9893347
Citations 8
Authors
Affiliations
Soon will be listed here.
Citing Articles

Neovascularization of engineered tissues for clinical translation: Where we are, where we should be?.

Nazeer M, Karaoglu I, Ozer O, Albayrak C, Kizilel S APL Bioeng. 2021; 5(2):021503.

PMID: 33834155 PMC: 8024034. DOI: 10.1063/5.0044027.


Hypoxia-regulated overexpression of soluble VEGFR2 controls angiogenesis and inhibits tumor growth.

Collet G, Lamerant-Fayel N, Tertil M, El Hafny-Rahbi B, Stepniewski J, Guichard A Mol Cancer Ther. 2013; 13(1):165-78.

PMID: 24170768 PMC: 3893111. DOI: 10.1158/1535-7163.MCT-13-0637.


Vascular endothelial growth factor-C, a potential paracrine regulator of glomerular permeability, increases glomerular endothelial cell monolayer integrity and intracellular calcium.

Foster R, Slater S, Seckley J, Kerjaschki D, Bates D, Mathieson P Am J Pathol. 2008; 173(4):938-48.

PMID: 18772335 PMC: 2543063. DOI: 10.2353/ajpath.2008.070416.


VEGF-C alters barrier function of cultured lymphatic endothelial cells through a VEGFR-3-dependent mechanism.

Breslin J, Yuan S, Wu M Lymphat Res Biol. 2007; 5(2):105-13.

PMID: 17935478 PMC: 3001341. DOI: 10.1089/lrb.2007.1004.


Effect of thiazolidinedione on the proliferation of bovine retinal endothelial cells stimulated by vascular endothelial cell growth factor.

Hiroishi G, Murata T, Ishibashi T Jpn J Ophthalmol. 2007; 51(1):21-6.

PMID: 17295136 DOI: 10.1007/s10384-006-0385-2.